U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C26H43NO5
Molecular Weight 449.6233
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GLYCOCHENODEOXYCHOLIC ACID

SMILES

C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

InChI

InChIKey=GHCZAUBVMUEKKP-GYPHWSFCSA-N
InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1

HIDE SMILES / InChI

Molecular Formula C26H43NO5
Molecular Weight 449.6233
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.
2015-02
Development of a multiparametric cell-based protocol to screen and classify the hepatotoxicity potential of drugs.
2012-05
Angiotensin II protects primary rat hepatocytes against bile salt-induced apoptosis.
2012
Role of bile salt in regulating Mcl-1 phosphorylation and chemoresistance in hepatocellular carcinoma cells.
2011-04-20
Survivin signaling is regulated through nuclear factor-kappa B pathway during glycochenodeoxycholate-induced hepatocyte apoptosis.
2010-12
Bile acid-induced virulence gene expression of Vibrio parahaemolyticus reveals a novel therapeutic potential for bile acid sequestrants.
2010-10-13
HepatoNet1: a comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology.
2010-09-07
Interpreting metabolomic profiles using unbiased pathway models.
2010-02-26
Calcium-dependent nitric oxide production is involved in the cytoprotective properties of n-acetylcysteine in glycochenodeoxycholic acid-induced cell death in hepatocytes.
2010-01-15
Mitochondrial-driven ubiquinone enhances extracellular calcium-dependent nitric oxide production and reduces glycochenodeoxycholic acid-induced cell death in hepatocytes.
2009-12
Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors.
2009-09
Bile acid-induced epidermal growth factor receptor activation in quiescent rat hepatic stellate cells can trigger both proliferation and apoptosis.
2009-08-14
Thermodynamics and structure of inclusion compounds of tauro- and glyco-conjugated bile salts and beta-cyclodextrin.
2009-07-07
Current concepts of mechanisms in drug-induced hepatotoxicity.
2009
Determination of intralumenal individual bile acids by HPLC with charged aerosol detection.
2008-12
Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury.
2008-09
Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes.
2008-08
Effects of bile acids on pancreatic ductal bicarbonate secretion in guinea pig.
2008-08
Cytoprotective effect of tauroursodeoxycholate on hepatocyte apoptosis induced by peroxisome proliferator-activated receptor gamma ligand.
2008-07
Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis.
2008
Complexation of tauro- and glyco-conjugated bile salts with three neutral beta-CDs studied by ACE.
2007-10
Bile salts regulate proliferation and apoptosis of liver cells by modulating the IGF1 system.
2007-07
Structural basis for bile salt inhibition of pancreatic phospholipase A2.
2007-06-01
Taurodeoxycholate modulates apical Cl-/OH- exchange activity in Caco2 cells.
2007-05
Glycochenodeoxycholate (GCDC) inhibits cytokine induced iNOS expression in rat hepatocytes.
2007-03
Hydrophobic bile salts induce hepatocyte shrinkage via NADPH oxidase activation.
2007
Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
2006-11
[Bile salts induce differentiation in cultured human normal esophageal mucosal epithelial cells].
2006-09-12
Characterization of fasted-state human intestinal fluids collected from duodenum and jejunum.
2006-08
Sulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.
2006-05
Substrate specificity of human ABCC4 (MRP4)-mediated cotransport of bile acids and reduced glutathione.
2006-04
Determinants of cooperativity and site selectivity in human ileal bile acid binding protein.
2006-01-24
Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage.
2005-12-01
Bile salts inhibit growth and induce apoptosis of culture human normal esophageal mucosal epithelial cells.
2005-11-07
Bile salts inhibit growth and induce apoptosis of human esophageal cancer cell line.
2005-09-07
Reversibility of caspase activation and its role during glycochenodeoxycholate-induced hepatocyte apoptosis.
2005-06-24
Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid.
2005-04
A nuclear receptor ligand down-regulates cytosolic phospholipase A2 expression to reduce bile acid-induced cyclooxygenase 2 activity in cholangiocytes: implications of anticarcinogenic action of farnesoid X receptor agonists.
2005-03
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
2005-01
Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
2005-01
Unique inhibition of bile salt-induced apoptosis by lecithins and cytoprotective bile salts in immortalized mouse cholangiocytes.
2003-12
Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation.
2003-09
Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
2003-08
Gallium-67 activated charcoal: a new method for preparation of radioactive capsules for colonic transit study.
2003-06
[Release of cytochrome C with the interaction of bilirubin, amyloid beta-peptide and glycochenodeoxycholate from isolated mitochondria].
2003-01-15
The human bile salt export pump: characterization of substrate specificity and identification of inhibitors.
2002-11
Membrane structural changes support the involvement of mitochondria in the bile salt-induced apoptosis of rat hepatocytes.
2002-11
The bcl-2 mRNA expression in GCDC-induced obstructive jaundice in rats and its implication in hepatocellular apoptosis.
2002
Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter.
1998-01
Binding of bile acids by glutathione S-transferases from rat liver.
1986-09
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:43:37 GMT 2025
Edited
by admin
on Mon Mar 31 20:43:37 GMT 2025
Record UNII
451ZNJ667Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
12-DEOXYCHOLYLGLYCINE
Preferred Name English
GLYCOCHENODEOXYCHOLIC ACID
Common Name English
CHENODEOXYGLYCOCHOLIC ACID
Common Name English
12-DESOXYCHOLYLGLYCINE
Common Name English
GLYCYLCHENODEOXYCHOLIC ACID
Common Name English
GLYCINE, N-(3.ALPHA.,7.ALPHA.-DIHYDROXY-5.BETA.-CHOLAN-24-OYL)-
Systematic Name English
GLYCINE, N-((3.ALPHA.,5.BETA.,7.ALPHA.)-3,7-DIHYDROXY-24-OXOCHOLAN-24-YL)-
Systematic Name English
CHENODEOXYCHOLYLGLYCINE
Common Name English
GLYCINE CHENODEOXYCHOLATE
Common Name English
Classification Tree Code System Code
LOINC 2066-9
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
Code System Code Type Description
WIKIPEDIA
Glycochenodeoxycholic acid
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
EPA CompTox
DTXSID301020165
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
CHEBI
36274
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
PUBCHEM
12544
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
DRUG BANK
DB02123
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
CAS
640-79-9
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
FDA UNII
451ZNJ667Y
Created by admin on Mon Mar 31 20:43:37 GMT 2025 , Edited by admin on Mon Mar 31 20:43:37 GMT 2025
PRIMARY
Related Record Type Details
TRANSPORTER -> SUBSTRATE